WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Talos Energy
TALO
$1.65B
| $6.99M | 0.04% |
+824,826
| New | +$6.99M |
|
502
Ocular Therapeutix
OCUL
$2.37B
| $6.97M | 0.04% |
750,950
| – | – |
|
503
Spyre Therapeutics
SYRE
$1.03B
| $6.96M | 0.04% |
465,152
+344
| +0.1% | +$5.15K |
|
504
Apollo Global Management
APO
$75.3B
| $6.93M | 0.04% |
48,829
+11,065
| +29% | +$1.57M |
|
505
Hilton Worldwide
HLT
$64B
| $6.85M | 0.04% |
25,712
+5,385
| +26% | +$1.43M |
|
506
Moderna
MRNA
$9.78B
| $6.81M | 0.04% |
246,973
+2,641
| +1% | +$72.9K |
|
507
Kura Sushi USA
KRUS
$985M
| $6.79M | 0.04% |
+78,856
| New | +$6.79M |
|
508
Marriott International Class A Common Stock
MAR
$71.9B
| $6.72M | 0.04% |
24,591
+5,259
| +27% | +$1.44M |
|
509
AutoZone
AZO
$70.6B
| $6.72M | 0.04% |
1,809
+391
| +28% | +$1.45M |
|
510
Xencor
XNCR
$610M
| $6.63M | 0.04% |
843,296
| – | – |
|
511
Entegris
ENTG
$12.4B
| $6.61M | 0.03% |
+82,009
| New | +$6.61M |
|
512
Chemours
CC
$2.34B
| $6.6M | 0.03% |
+576,315
| New | +$6.6M |
|
513
Vaxcyte
PCVX
$4.29B
| $6.5M | 0.03% |
200,078
-911,699
| -82% | -$29.6M |
|
514
Hayward Holdings
HAYW
$3.52B
| $6.41M | 0.03% |
+464,643
| New | +$6.41M |
|
|
TECX
515
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $6.39M | 0.03% |
321,637
+19,422
| +6% | +$386K |
|
516
Kenvue
KVUE
$35.7B
| $6.37M | 0.03% |
304,205
-469,661
| -61% | -$9.83M |
|
517
Emerson Electric
EMR
$74.6B
| $6.36M | 0.03% |
+47,717
| New | +$6.36M |
|
518
Nektar Therapeutics
NKTR
$764M
| $6.36M | 0.03% |
246,145
+20
| +0% | +$517 |
|
519
Monolithic Power Systems
MPWR
$41.5B
| $6.25M | 0.03% |
+8,541
| New | +$6.25M |
|
520
GE HealthCare
GEHC
$34.6B
| $6.24M | 0.03% |
84,276
+30,092
| +56% | +$2.23M |
|
521
Fulcrum Therapeutics
FULC
$414M
| $6.18M | 0.03% |
897,617
| – | – |
|
522
Kinder Morgan
KMI
$59.1B
| $6.15M | 0.03% |
209,118
+45,800
| +28% | +$1.35M |
|
|
UPB
523
Upstream Bio, Inc. Common Stock
UPB
$1.08B
| $6.13M | 0.03% |
558,252
+1,189
| +0.2% | +$13.1K |
|
524
RingCentral
RNG
$2.89B
| $6.11M | 0.03% |
215,496
+56,022
| +35% | +$1.59M |
|
525
Truist Financial
TFC
$60B
| $6.09M | 0.03% |
141,651
+30,474
| +27% | +$1.31M |
|